NovoCure Ltd (NVCR)
12.72
-0.85
(-6.26%)
USD |
NASDAQ |
Apr 15, 16:00
12.70
-0.02
(-0.16%)
After-Hours: 07:17
NovoCure Gross Profit Margin (Quarterly): 75.67% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 75.67% |
| September 30, 2023 | 74.79% |
| June 30, 2023 | 73.01% |
| March 31, 2023 | 75.76% |
| December 31, 2022 | 77.51% |
| September 30, 2022 | 77.29% |
| June 30, 2022 | 79.77% |
| March 31, 2022 | 79.84% |
| December 31, 2021 | 77.71% |
| September 30, 2021 | 77.39% |
| June 30, 2021 | 78.58% |
| March 31, 2021 | 80.41% |
| December 31, 2020 | 80.45% |
| September 30, 2020 | 78.60% |
| June 30, 2020 | 78.03% |
| March 31, 2020 | 75.94% |
| December 31, 2019 | 75.02% |
| September 30, 2019 | 75.13% |
| June 30, 2019 | 75.66% |
| Date | Value |
|---|---|
| March 31, 2019 | 72.97% |
| December 31, 2018 | 66.95% |
| September 30, 2018 | 70.74% |
| June 30, 2018 | 67.76% |
| March 31, 2018 | 65.01% |
| December 31, 2017 | 70.85% |
| September 30, 2017 | 69.76% |
| June 30, 2017 | 65.73% |
| March 31, 2017 | 66.56% |
| December 31, 2016 | 63.72% |
| September 30, 2016 | 48.70% |
| June 30, 2016 | 9.54% |
| March 31, 2016 | 38.85% |
| December 31, 2015 | 49.09% |
| September 30, 2015 | 36.79% |
| June 30, 2015 | 27.40% |
| March 31, 2015 | 25.17% |
| December 31, 2014 | 30.81% |
| September 30, 2014 | 40.88% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
73.01%
Minimum
Jun 2023
80.45%
Maximum
Dec 2020
77.19%
Average
77.39%
Median
Sep 2021
Gross Profit Margin (Quarterly) Benchmarks
| AtriCure Inc | 74.91% |
| NeuroMetrix Inc | 64.35% |
| Repligen Corp | 43.41% |
| Teleflex Inc | 55.75% |
| Perspective Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.62% |
| Return on Assets | -17.79% |
| Return on Invested Capital | -21.21% |
| Profit Margin (Quarterly) | -35.19% |
| Operating Margin (Quarterly) | -38.66% |
| Return on Net Operating Assets | -94.21% |